WHITE PLAINS, N.Y., May 1, 2026 /PRNewswire/ -- Retia Medical today announced the first public presentation of results from its non-invasive cardiac output algorithm, which estimates cardiac output ...
Catheter Precision, Inc. has announced its first purchase order for the VIVO product from Sahlgrenska University Hospital in Sweden, which is the largest hospital in the country and has a substantial ...
Encouraging 12-month pilot clinical study results will be presented by Key Opinion Leader Dr. Lowell Kabnick at the prestigious Charing Cross Vascular Symposium in London on Tuesday, April 21st, 2026.
BioCardia announces the granting of a patent in Japan for its innovative catheter technology, enhancing cell therapy delivery to the heart. BioCardia, Inc. announced the granting of Japanese Patent No ...
Doctors may soon be able to tell just how sick a heart failure patient really is by using a routine MRI scan, thanks to new research from the University of East Anglia. People with heart failure often ...
SAN FRANCISCO, September 29, 2025 — Radiation therapy may offer a comparable and potentially safer alternative to repeat catheter ablation for patients with severe abnormal heart rhythms that can no ...
Inlexzo is an intravesical gemcitabine releasing system that is inserted directly into the bladder through a urinary catheter. The Food and Drug Administration (FDA) has approved Inlexzo ™ ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results